Boostagen-2 Dosage/Direction for Use

Posology: A single 0.5 mL dose of Boostagen-2 is recommended.
Boostagen-2 should be given in accordance with WHO and national recommendations or medical practices for booster vaccination and for maternal immunization: in the second or third trimester and preferably at least 15 days before the end of pregnancy; in adolescents and adults with an unknown or incomplete immunization against diphtheria or tetanus as part of vaccination program; for tetanus prophylaxis in wound management. Tetanus immunoglobulin should be administered in accordance with existing recommendations.
Administration: Boostagen-2 should be administered by deep intramuscular injection, preferably in the deltoid region. The skin over the site of injection should be cleaned with alcohol before injection. Shake well before use. Do not use if resuspension does not occur after vigorous shaking. Open the cap of the pre-filled syringe or vial, administer 0.5 mL intramuscularly (IM). Opened multi-dose vial should be discarded at the end of the immunization or within six hours after opening, whichever comes first.